German and Chinese Ibuprofen price increased from August to September as both markets expected to further rise during 2025. External economic pressures, changes in consumer behavior, and enhanced demand in the pharma segment compel the growth. Demand and supply factors in the German and Chinese market dictate the Ibuprofen market. On the demand side, increased consumption and awareness of over-the-counter analgesics, particularly in pharmaceuticals and healthcare, are the decisive forces, as consumers become increasingly selective of readily available remedies for everyday distress. Supply-side forces are also important, with changes in levels of production, stock levels, and raw materials prices. China, as a leading producer and exporter of Ibuprofen, holds a vital position in the world supply chain, providing consistent exports to fulfill international demands. At the same time, Germany, as one of the leading importers, is highly reliant on Chinese supplies, making it susceptible to production or price disruption. All these examples depict the market sensitivity towards global economic movements, which can attract the prices upwards in the next couple of years.
